Skip to main content

Want a detailed portfolio tracker?

Kyverna Therapeutics (KYTX) P/E (2024 - 2026)

Kyverna Therapeutics (KYTX) P/E from Apr 1, 2024 to Jul 21, 2026. The TTM Kyverna Therapeutics (KYTX) P/E is -2.42. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Kyverna Therapeutics (KYTX)

YearP/EChange
2026-2.42-10.75%
2025-2.71+113.79%
2024-1.27N/A

Comparison Kyverna Therapeutics (KYTX) P/E with competitors

Kyverna Therapeutics (KYTX) P/E is -2.42.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.00-100.18%
ENLVEnlivex Ltd0.07-103.10%
FGENFibroGen Inc0.24-109.93%
CHRSCoherus Biosciences Inc0.85-135.11%
FBIOFortress Biotech Inc0.95-139.27%
ORMPOramed Pharmaceuticals Inc1.50-162.20%
AGENAgenus Inc3.01-224.54%
INVAInnoviva Inc3.15-230.52%
VXRTVaxart Inc3.55-246.89%
CRMDCorMedix Inc3.63-250.15%
CVACCureVac N.V.4.45-283.97%
GLPGGalapagos NV4.86-301.06%
SRPTSarepta Therapeutics Inc4.88-302.02%
ABEOAbeona Therapeutics Inc5.39-322.94%
ABUSArbutus Biopharma Corp5.60-331.55%
ZVRAZevra Therapeutics Inc5.89-343.62%
SPROSpero Therapeutics Inc6.23-357.74%
CGENCompugen Ltd6.31-361.28%
RIGLRigel Pharmaceuticals6.87-384.37%
SLXNSilexion Therapeutics Corp7.30-401.92%
OMEROmeros Corporation9.26-483.13%
AUPHAurinia Pharmaceuticals Inc9.58-496.63%
PLXProtalix BioTherapeutics Inc10.89-550.68%
ACADAcadia Pharmaceuticals Inc11.73-585.34%
TBPHTheravance Biopharma Inc12.26-607.42%
ADMAAdma Biologics Inc12.42-613.87%
HRMYHarmony Biosciences Holdings Inc13.82-671.89%
SABSSAB Biotherapeutics Inc14.14-684.97%
NAGENiagen Bioscience Inc14.82-713.19%
INCYIncyte Corp15.82-754.75%
REGNRegeneron Pharmaceuticals Inc15.86-756.16%
PBYIPuma Biotechnology Inc17.32-816.54%
CPRXCatalyst Pharmaceuticals Inc17.44-821.66%
EXELExelixis Inc17.54-825.74%
TGTXTG Therapeutics Inc18.97-884.83%
MDXGMimedx Group Inc20.55-950.48%
XOMAXOMA Royalty Corp22.87-1046.60%
ARGXArgen X SE24.30-1105.50%
CTMXCytomX Therapeutics Inc24.82-1127.15%
XOMAOXOMA Royalty Corp25.34-1148.82%
HALOHalozyme Therapeutics Inc25.62-1160.36%
XOMAPXOMA Royalty Corp25.67-1162.28%
VRTXVertex Pharmaceuticals Inc27.99-1258.48%
RPRXRoyalty Pharma plc - Class A28.69-1287.15%
SLNOSoleno Therapeutics Inc29.02-1300.71%
ASNDAscendis Pharma A/S30.09-1345.00%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1668.88%
APLSApellis Pharmaceuticals Inc39.02-1714.78%
BMRNBiomarin Pharmaceutical Inc42.21-1846.81%
KRYSKrystal Biotech Inc45.34-1976.41%
ONCBeiGene Ltd69.54-2977.73%
PHARPharming Group N.V.75.03-3204.72%
TECHBio-Techne Corp101.96-4319.25%
VCELVericel Corp109.92-4648.77%
ALNYAlnylam Pharmaceuticals Inc117.96-4981.64%
GMABGenmab140.29-5905.53%
TLXTelix Pharmaceuticals Ltd162.15-6810.22%
CORTCorcept Therapeutics Inc212.86-8908.49%